Kim Kelderman serves as the Chief Executive Officer of Bio-Techne Corporation. Taking on this leadership role, he is responsible for overseeing the company's long-term strategic vision, global operations, and financial performance. As the leader of a major life sciences tools provider, he guides the corporation’s efforts in scaling its presence in protein science, diagnostic reagents, and cell therapy manufacturing tools. His executive responsibilities include managing the firm's extensive R&D pipelines, guiding the integration of recent strategic acquisitions, and ensuring that the corporation remains a critical supplier to the global pharmaceutical and biotechnology research industries. He works closely with the Board of Directors to navigate the complexities of the rapidly evolving life sciences market, maintaining the company's reputation for quality, innovation, and reliability among its international customer base of academic researchers and pharmaceutical developers.